You are here: Industry Insights > Sinovac

News List

Sinovac’s Covid-19 vaccine trial triggers immune responses in children pharmaceutical-technology
March 24, 2021
China-based company Sinovac Biotech has reported that preliminary results from Phase I and II clinical trials of its Covid-19 vaccine, CoronaVac, demonstrated it to be safe and could induce immune responses among children and adolescents.
Sinovac’s Covid-19 vaccine gets approval in Thailand for emergency use pharmaceutical-technology
February 25, 2021
Chinese company Sinovac Biotech has obtained approval for its Covid-19 vaccine from Thailand’s Food and Drug Administration (FDA) for local emergency use prior to the launch of a vaccination programme in the country.
China grants conditional approval to 2nd COVID-19 vaccine expresspharma
February 07, 2021
China has granted conditional approval for its second COVID-19 vaccine, ahead of the expected emergency approval from the WHO for two of its jabs that would enable the country to step-up global supplies of the shots.
Sinovac get $515 mn funding for COVID-19 vaccine production expresspharma
December 08, 2020
Sinovac said that it would be able to manufacture 300 million vaccine doses annually and aims to complete construction of a second production facility by the end of 2020 to increase annual COVID-19 vaccine production capacity to 600 million doses.
SinoVac gets authorisation to restart Covid-19 vaccine trial in Brazil pharmaceutical-technology
November 12, 2020
Chinese biopharmaceutical firm Sinovac is set to resume the Phase III trial of the Inactivated Covid-19 vaccine, CoronaVaC, after the Brazil National Health Surveillance Agency (Anvisa) authorised its resumption.
Sinovac reports preliminary Phase I/II results of COVID-19 vaccine in elderly volunteers worldpharmanews
September 24, 2020
Sinovac Biotech Ltd. ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, announced that the inactivated COVID-19 vaccine candidate developed by Sinovac Life Sciences (Sinovac LS), or "CoronaVac,"shows good safety ...
Sinovac’s COVID-19 vaccine candidate get emergency use approval in China expresspharma
August 31, 2020
Sinovac Biotech’s coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.
Sinovac signs agreement with Bio Farma Indonesia for Covid-19 vaccine cooperation pharmaceutical-business-review
August 27, 2020
Sinovac Biotech, a leading provider of biopharmaceutical products in China, announced it has signed two agreements in Hainan, China with PT Bio Farma, a leading biopharmaceutical company in Indonesia, for the supply ...
China’s indigenously developed COVID-19 vaccines set to surprise the world: GlobalData expresspharma
July 21, 2020
China's Sinopharm and Sinovac (in collaboration with Brazil-based Butantan) have both reported encouraging results in the early phases of human testing for COVID-19.
Brazil to test Sinovac’s potential vaccine against COVID-19 in six states expresspharma
July 03, 2020
The agreement with Sinovac includes not only trials but also the transference of technology to produce the coronavirus vaccine locally.

Previous page 1 2 3 Next page